Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China · Delayed Price · Currency is CNY 18.44
-0.20 (-1.07%)
Apr 9, 2026, 10:00 AM CST
SHE:300119 Revenue
In the year 2025, Tianjin Ringpu Bio-Technology had annual revenue of 3.40B CNY with 10.70% growth. Tianjin Ringpu Bio-Technology had revenue of 854.13M in the quarter ending December 31, 2025, with 3.12% growth.
Revenue
3.40B
Revenue Growth
+10.70%
P/S Ratio
2.49
Revenue / Employee
1.17M
Employees
2,900
Market Cap
8.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.40B | 328.53M | 10.70% |
| Dec 31, 2024 | 3.07B | 360.83M | 13.32% |
| Dec 31, 2023 | 2.71B | 624.85M | 29.98% |
| Jan 1, 2023 | 2.08B | 77.11M | 3.84% |
| Jan 1, 2022 | 2.01B | 6.73M | 0.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.28B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Zhejiang Tianyu Pharmaceutical | 2.99B |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 2.25B |
| Jiuzhitang | 2.23B |
| Guangxi Wuzhou Zhongheng Group | 1.75B |